Daniel Cuttica, DO
Foot and Ankle Surgery · Falls Church, VANPI 1659580298
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $104,168 of the $143,340 with a category attached, or 72.7%. 41 manufacturers reported payments, led by Linvatec Corporation at 44.2% of the total. 2025 is the largest year on record at $35,282, 3.2 times the $10,966 reported in 2019. Among foot and ankle surgery clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 202 payments — averaging $709.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Linvatec Corporation$63K
- International Life Sciences$32K
- Medartis Inc.$20K
- Treace Medical Concepts, Inc.$7K
- Stryker$7K
- In2bones USA, LLC$5K
- plus $8K from 35 others
Across 3 payments — averaging $11,073 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Stryker$33K
What the payments were for
- Royalty or licence$7,6295%
- Consulting fees$104,16873%
- Grants$2,5002%
- Travel & lodging$18,33013%
- Food & beverage$6,6565%
- Education$4,0583%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Linvatec Corporation | 57 | $63,320 |
| International Life Sciences | 14 | $32,433 |
| Medartis Inc. | 14 | $19,752 |
| Treace Medical Concepts, Inc. | 5 | $7,400 |
| Stryker | 19 | $7,064 |
| In2bones USA, LLC | 7 | $5,437 |
| Supreme Orthopedic Systems, LLC | 7 | $4,249 |
| Smith+Nephew | 10 | $554 |
| Integra Lifesciences Corporation | 9 | $356 |
| Organogenesis Inc. | 10 | $297 |
| Novastep Inc. | 3 | $280 |
| Arthrex | 2 | $229 |
| Zimmer Biomet | 2 | $222 |
| Medline Industries LP | 2 | $201 |
| Paragon 28, Inc. | 2 | $191 |
| Amgen(2 entities) | 8 | $173 |
| DJO, LLC | 1 | $168 |
| Restor3d, Inc. | 1 | $102 |
| Crossroads Extremity Systems, LLC | 1 | $99 |
| Nextremity Solutions Inc. | 1 | $95 |
| Convatec Inc. | 3 | $93 |
| Theramicro, Inc. | 1 | $92 |
| Pacira Pharmaceuticals Incorporated | 3 | $71 |
| Bioventus LLC | 2 | $55 |
| Acumed LLC | 1 | $48 |
| Kerecis Limited | 2 | $38 |
| Innovation Technologies Inc | 1 | $35 |
| One Surgical, Inc. | 1 | $34 |
| Abbott | 1 | $27 |
| Johnson & Johnson | 1 | $25 |
| Bone Support Inc. | 1 | $24 |
| IBSA Pharma Inc. | 1 | $24 |
| Progenacare Global, LLC | 1 | $23 |
| Fidia Pharma USA Inc. | 1 | $23 |
| Heron Therapeutics, Inc. | 1 | $21 |
| Tactile Systems Technology Inc | 1 | $17 |
| Curonix LLC | 1 | $15 |
| Cashflow Solutions, LLC | 1 | $15 |
| Medtronic | 1 | $13 |
| Avanos Medical | 1 | $13 |
| Next Science LLC | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- IBS$63,944
- FLEXBAND$29,425
- APTUS$19,588
- Lapiplasty System$7,400
- COLINK PLATING SYSTEM$3,281
- Quantum Total Ankle$2,100
- QUANTUM$667
- 1788$599
- mild Device Kit$450
- INTEGRA$412
- AUGMENT INJECTABLE$321
- BioBrace 23mm$225
- PECA Bunion Correction System$213
- VARIAX$175
- PROCARE$168
- ALLOMATRIX$152
- COLINK 2$151
- COLINK VALLUX$151
- Bone Anchors with Arthroscopic Delivery System$140
- Q-FIX$140
How this compares
$143,340 in reported general payments places this provider in the 95th percentile of 260 foot and ankle surgery providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Meloxicam | 27 | $42 |
Paid to pharmacies, not to this prescriber.
Other foot and ankle surgery in Falls Church
- Steven NeufeldFalls Church$857K
- Thomas SandersFalls Church$41K
- Trevor KlinknerFalls Church$17K
- Mark JonesNorth Chesterfield$2.4M
- Oliver SchipperArlington$1.2M
- Charles ZelenRoanoke$363K
- Ryan VazalesGlen Allen$337K
- Jugal DhariaFairfax$309K
- William SimonVirginia Beach$292K
- William GrantVirginia Beach$271K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.